Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 534-539

  Lee, Boris P L ^a,b   Juvet, Stephen C ^a,c,d   Zhang, Li ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Medicine   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Double negative T cells; E prostanoid receptor 2; Prostaglandin E2; Regulatory T cells

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BETA ACTIN; BUTAPROST; CD4 ANTIGEN; CD8 ANTIGEN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; LYMPHOCYTE ANTIGEN RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E1; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PTGER2 PROTEIN, MOUSE; XANTHONE DERIVATIVE;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL EXPANSION; CELL KILLING; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOTOXICITY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ALPROSTADIL; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL PROLIFERATION; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DINOPROSTONE; IMMUNOMAGNETIC SEPARATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, PROSTAGLANDIN E; T-LYMPHOCYTES, REGULATORY; XANTHONES; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE;

EID: 63549117616     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.023     Document Type: Article

References (46)

1. Jiang S., Lechler R.I., He X.S., and Huang F.J. Regulatory T cells and transplantation tolerance. Hum Immunol 67 10 (2006) 765-776
2. Pennington D.J., Vermijlen D., Wise E.L., Clarke S.L., Tigelaar R.E., and Hayday A.C. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv Immunol 87 (2005) 27-59
3. Thomson C.W., Lee B.P., and Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35 1-2 (2006) 163-178
4. Zhang Z.X., Yang L., Young K.J., DuTemple B., and Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6 7 (2000) 782-789
5. Fischer K., Voelkl S., Heymann J., Przybylski G.K., Mondal K., Laumer M., et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105 7 (2005) 2828-2835
6. Young K.J., DuTemple B., Phillips M.J., and Zhang L. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 171 1 (2003) 134-141
7. Chen W., Ford M.S., Young K.J., Cybulsky M.I., and Zhang L. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 170 4 (2003) 1846-1853
8. Chen W., Zhou D., Torrealba J.R., Waddell T.K., Grant D., and Zhang L. Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J Immunol 175 5 (2005) 3409-3416
9. Ford M.S., Young K.J., Zhang Z., Ohashi P.S., and Zhang L. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 196 2 (2002) 261-267
10. Ma Y., He K.M., Garcia B., Min W., Jevnikar A., and Zhang Z.X. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation. Xenotransplantation 15 1 (2008) 56-63
11. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity 19 2 (2003) 165-168
12. Dolganiuc A., Paek E., Kodys K., Thomas J., and Szabo G. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135 6 (2008) 2119-2127
13. Wei G., and Tabel H. Regulatory T cells prevent control of experimental African trypanosomiasis. J Immunol 180 4 (2008) 2514-2521
14. Bignone P.A., and Banham A.H. FOXP3+ regulatory T cells as biomarkers in human malignancies. Expert Opin Biol Ther 8 12 (2008) 1897-1920
15. Sharma S., Yang S.C., Zhu L., Reckamp K., Gardner B., Baratelli F., et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res 65 12 (2005) 5211-5220
16. Salama P., Phillips M., Grieu F., Morris M., Zeps N., Joseph D., et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27 2 (2008) 186-192
17. Voelkl S., Moore T.V., Rehli M., Nishimura M.I., Mackensen A., and Fischer K. Characterization of MHC class-I restricted TCRalphabeta(+) CD4 (-) CD8 (-) double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination. Cancer Immunol Immunother (2008) Epub ahead of print
18. Young K.J., Kay L.S., Phillips M.J., and Zhang L. Antitumor activity mediated by double-negative T cells. Cancer Res 63 22 (2003) 8014-8021
19. Antonelli L.R., Dutra W.O., Oliveira R.R., Torres K.C., Guimaraes L.H., Bacellar O., et al. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect Immun 74 11 (2006) 6317-6323
20. Cowley S.C., Hamilton E., Frelinger J.A., Su J., Forman J., and Elkins K.L. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med 198 3 (2003) 379-389
21. Cowley S.C., Hamilton E., Frelinger J.A., Su J., Forman J., and Elkins K.L. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med 202 2 (2005) 309-319
22. Marra L.E., Zhang Z.X., Joe B., Campbell J., Levy G.A., Penninger J., et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J Immunol 172 2 (2004) 1028-1035
23. Bos C.L., Richel D.J., Ritsema T., Peppelenbosch M.P., and Versteeg H.H. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36 7 (2004) 1187-1205
24. Tilley S.L., Coffman T.M., and Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108 1 (2001) 15-23
25. Sugimoto Y., and Narumiya S. Prostaglandin E receptors. J Biol Chem 282 16 (2007) 11613-11617
26. Betz M., and Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146 1 (1991) 108-113
27. Khayrullina T., Yen J.H., Jing H., and Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 181 1 (2008) 721-735
28. Sheibanie A.F., Yen J.H., Khayrullina T., Emig F., Zhang M., Tuma R., et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J Immunol 178 12 (2007) 8138-8147
29. Chouaib S., Welte K., Mertelsmann R., and Dupont B. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. J Immunol 135 2 (1985) 1172-1179
30. Jarvinen L., Badri L., Wettlaufer S., Ohtsuka T., Standiford T.J., Toews G.B., et al. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 181 6 (2008) 4389-4396
31. Lee B.P., Mansfield E., Hsieh S.C., Hernandez-Boussard T., Chen W., Thomson C.W., et al. Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 174 8 (2005) 4535-4544
32. Baratelli F., Lin Y., Zhu L., Yang S.C., Heuze-Vourc'h N., Zeng G., et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 175 3 (2005) 1483-1490
33. Hendricks A., Leibold W., Kaever V., and Schuberth H.J. Prostaglandin E2 is variably induced by bacterial superantigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response. Immunobiology 201 5 (2000) 493-505
34. Nataraj C., Thomas D.W., Tilley S.L., Nguyen M.T., Mannon R., Koller B.H., et al. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest 108 8 (2001) 1229-1235
35. Okano M., Sugata Y., Fujiwara T., Matsumoto R., Nishibori M., Shimizu K., et al. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. Immunology 118 3 (2006) 343-352
36. Mastino A., Piacentini M., Grelli S., Favalli C., Autuori F., Tentori L., et al. Induction of apoptosis in thymocytes by prostaglandin E2 in vivo. Dev Immunol 2 4 (1992) 263-271
37. Pica F., Franzese O., D'Onofrio C., Bonmassar E., Favalli C., and Garaci E. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J Pharmacol Exp Ther 277 3 (1996) 1793-1800
38. Gardiner P.J. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br J Pharmacol 87 1 (1986) 45-56
39. Woodward D.F., Pepperl D.J., Burkey T.H., and Regan J.W. 6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem Pharmacol 50 10 (1995) 1731-1733
40. Mahic M., Yaqub S., Johansson C.C., Tasken K., and Aandahl E.M. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177 1 (2006) 246-254
41. Fischer K., Voelkl S., Heymann J., Przybylski G.K., Mondal K., Laumer M., et al. Isolation and characterization of human antigen-specific TCRalphabeta+ CD4-CD8- double-negative regulatory T cells. Blood 105 (2005) 2828-2835
42. Reddy P., Teshima T., Kukuruga M., Ordemann R., Liu C., Lowler K., et al. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 194 10 (2001) 1433-1440
43. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140 5 (1988) 1506-1510
44. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158 11 (1997) 5501-5506
45. Sabatino Jr. J.J., Shires J., Altman J.D., Ford M.L., and Evavold B.D. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J Immunol 180 7 (2008) 4451-4457
46. Vermeire K., Heremans H., Vandeputte M., Huang S., Billiau A., and Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 158 11 (1997) 5507-5513